Get started
Author

Ryotaro Morinaga

Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
2007 · Ryotaro Morinaga, Isamu Okamoto, et al. · Lung Cancer · 118
Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
2010 · Isamu Okamoto, Hiroyasu Kaneda, et al. · Molecular Cancer Therapeutics · 94
PDF
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring EGFR mutations
2017 · Kentaro Tanaka, Kaname Nosaki, et al. · Oncotarget · 84
PDF
Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)
2017 · Eiji Iwama, Yasushi Goto, et al. · Journal of Thoracic Oncology · 52
A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
2021 · Daichi Fujimoto, Satoru Miura, et al. · JTO Clinical and Research Reports · 48
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer
2009 · Isamu Okamoto, Masaki Miyazaki, et al. · Investigational New Drugs · 45
PDF
Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non‐small cell lung cancer
2008 · Ryotaro Morinaga, Isamu Okamoto, et al. · Cancer Science · 37
Histologic transformation of epidermal growth factor receptor–mutated lung cancer
2022 · Daichi Fujimoto, Hiroaki Akamatsu, et al. · European Journal of Cancer · 36
A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors
2016 · K. Watanabe, S. Otsu, et al. · Cancer Chemotherapy and Pharmacology · 33
Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
2016 · Shinya Sakata, Sho Saeki, et al. · Lung Cancer · 29
A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).
2011 · N. Yamamoto, N. Katakami, et al. · Journal of Clinical Oncology · 25
Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer
2018 · Yuko Kawano, Tomonari Sasaki, et al. · Lung Cancer · 19
Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B
2011 · Hidetoshi Hayashi, Junji Tsurutani, et al. · Breast Cancer · 18
Phase II Trial of Erlotinib for Japanese Patients With Previously Treated Non-small-cell Lung Cancer Harboring EGFR Mutations: Results of Lung Oncology Group in Kyushu (LOGiK0803)
2013 · Kazuhiko Yamada, Koichi Takayama, et al. · Japanese Journal of Clinical Oncology · 16
High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
2021 · Atsushi Osoegawa, Masafumi Yamaguchi, et al. · JTO Clinical and Research Reports · 15
PDF
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401
2019 · Eiji Iwama, Yasushi Goto, et al. · The Oncologist · 15
PDF
In vitro and in vivo potency of polymyxin B against IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa
2008 · Yoshiko Miyajima, Kazufumi Hiramatsu, et al. · International Journal of Antimicrobial Agents · 14
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
2023 · Daichi Fujimoto, Satoru Miura, et al. · Scientific Reports · 13
PDF
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
2020 · Yasushi Hisamatsu, Ryotaro Morinaga, et al. · American Journal of Case Reports · 13
PDF
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer
2021 · Shota Omori, Hideyuki Harada, et al. · Investigational New Drugs · 9
PDF
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer
2019 · Yuko Tsuchiya-Kawano, Tomonari Sasaki, et al. · The Oncologist · 9
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
2010 · Koichiro Watanabe, Satoshi Otsu, et al. · BMC Gastroenterology · 8
PDF
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
2022 · Hisashi Tanaka, Shigeru Tanzawa, et al. · Therapeutic Advances in Medical Oncology · 7
[Case of toxocariasis showing migratory nodular shadows with halos].
2008 · Yasushi Hisamatsu, Hiroshi Ishii, et al. · PubMed · 6
Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab
2014 · Satoshi Otsu, Yoshinori Hirashima, et al. · Japanese Clinical Medicine · 5
PDF
Works count: 57
Citation count: 797
H-index: 15
I10-index: 19
Year
Topic
Type